Tylenol Liver Failure & Drug Injury Lawsuit


Studies have shown that acetaminophen, which is sold under the brand name Tylenol, is a leading cause of acute liver failure.

As of May 2013 there were approximately 190 plaintiffs suing the New Jersey-based McNeil PPC, Tylenol’s manufacturer, and McNeil’s parent company, Johnson & Johnson, in state and federal courts. The suits allege that Tylenol caused the plaintiffs or their loved ones to suffer severe liver damage.

The U.S. Food and Drug Administration (FDA) has also announced that acetaminophen might cause rare but serious skin reactions.

Tylenol Liver Damage Victim Awarded $8.8 Million

A federal court jury in Virginia in 1994 awarded $7.855 million in compensatory damages and an additional $1 million in punitive damages to a 39-year-old man who claimed that the loss of his liver was the result of his taking Tylenol in combination with his regular consumption of wine at dinner.

That plaintiff, former White House aide Antonio Benedi, slipped into a coma after taking Tylenol Extra Strength in the recommended doses to treat the flu. Doctors found he was suffering from liver failure and Benedi had a liver transplant several days later.

Since Benedi’s case, dozens of patients who claim they suffered liver damage from Tylenol have filed suit in federal and state courts. The Judicial Panel on Multidistrict Litigation centralized 21 of the federal actions into MDL No. 2436 in the U.S. District Court for the Eastern District of Pennsylvania on April 1, 2013, and—as of May 2103—there were at least 14 cases against McNeil and its parent company Johnson & Johnson in New Jersey state court alone.

The FDA Required Acetaminophen Label Changes in 2009 & 2013

In the spring of 2009, the U.S. Food and Drug Administration (FDA) required that Tylenol and generic acetaminophen product labels contain new warnings that highlight the potential for liver toxicity and warn consumers against using more than the recommended dose of acetaminophen, using more than one product (over-the-counter or prescription) containing acetaminophen, and taking acetaminophen with even moderate amounts of alcohol.

In the summer of 2013, the FDA announced that acetaminophen is associated with rare but severe and sometimes fatal skin reactions. The announcement was a reaction to three published reports in which individuals developed Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN), or acute generalized exanthematous pustulosis (AGEP) following administration of acetaminophen.

“Also, a search of adverse event reports submitted to the FDA yielded 91 cases of Stevens-Johnson syndrome or TEN and another 16 cases of AGEP that were linked to acetaminophen,” according to Medpage Today. “Twelve of those cases were fatal and 67 involved hospitalization.”

“The FDA said it would order a new warning for labels on all prescription products containing acetaminophen indicating a risk for severe skin reactions, and will request that manufacturers of over-the-counter products add such warnings,” Medpage Today reported.

RLG Lawyers Will Make Things Easier

If you believe that you or someone you love has developed liver failure or suffered some other serious adverse side effect as a result of taking Tylenol, submit this simple secure form for a free and confidential evaluation to learn more about your eligibility to file a Tylenol lawsuit.

Legal action is the best way to recover the most compensation for medical bills, lost wages, pain and suffering, and other damages. The Tylenol lawyers at the Rottenstein Law Group do everything possible to streamline the process of helping liver damage sufferers get the compensation they deserve.

Join the Discussion

Please note: Comments are encouraged in order to permit visitors to discuss relevant topics. Comments are moderated and might be edited by RLG before being published.

Comments should not be used to ask questions of RLG’s lawyers; if you want to speak with a lawyer, please fill out this contact form or call 1 (888) 976-8529. *Your name and email address will not be published.



RLG encourages you to reproduce our original content—on your own web site; in emails to your friends and family; in blogs, posts, and tweets, etc.—but we ask that you please attribute whatever you use to us, and, whenever possible, provide a link to the page where you first found the material. That way, whoever reads your excerpt might read more informative material of interest at one of RLG's sites.
You’ve taken enough. We'll take it from here. Click here to contact us now.